Cumberland Pharmaceuticals (CPIX) Common Equity (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Common Equity of $51.7 million for Q1 2026, up 107.92% sequentially from $24.9 million in Q4 2025, and up 82.53% YoY from $28.3 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Common Equity (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Common Equity for 17 years, with the latest figure at $51.7 million in Q1 2026.
- Quarterly Common Equity rose 82.53% year-over-year to $51.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.7 million (up 82.53% YoY) and the FY2025 annual result came in at $24.9 million, up 10.35% from the prior year.
- Common Equity improved to $51.7 million in Q1 2026 per CPIX's latest filing, from $24.9 million in the prior quarter.
- Over five years, Common Equity peaked at $51.7 million in Q1 2026 and troughed at $22.5 million in Q4 2024.
- A 5-year average of $32.5 million and a median of $29.3 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2026: Common Equity plunged 31.37% in 2024, then soared 82.53% in 2026.
- Over 5 years, Common Equity stood at $36.0 million in 2022, then decreased by 18.66% to $29.3 million in 2023, then decreased by 22.95% to $22.5 million in 2024, then climbed by 10.35% to $24.9 million in 2025, then soared by 107.92% to $51.7 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $51.7 million, $24.9 million, and $26.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | 51.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.81 Mn |
| Mar 31, 2026 | 51.73 Mn |
| Dec 31, 2025 | 24.88 Mn |
| Sep 30, 2025 | 26.12 Mn |
| Jun 30, 2025 | 27.68 Mn |
| Mar 31, 2025 | 28.34 Mn |
| Dec 31, 2024 | 22.55 Mn |
| Sep 30, 2024 | 24.47 Mn |
| Jun 30, 2024 | 26.03 Mn |
| Mar 31, 2024 | 27.19 Mn |
| Dec 31, 2023 | 29.26 Mn |
| Sep 30, 2023 | 35.66 Mn |
| Jun 30, 2023 | 36.84 Mn |
| Mar 31, 2023 | 36.05 Mn |
| Dec 31, 2022 | 35.97 Mn |
| Sep 30, 2022 | 38.89 Mn |
| Jun 30, 2022 | 39.20 Mn |
| Mar 31, 2022 | 40.79 Mn |
| Dec 31, 2021 | 42.60 Mn |
| Sep 30, 2021 | 46.65 Mn |